决明提取物(Senna Extract) - 在研适应症：便秘_专利_临床

概要

基本信息

药物类型

中药

别名

YODEL-S、ヨーデルS

靶点-

作用方式-

作用机制-

治疗领域

其他疾病

在研适应症

便秘

非在研适应症-

原研机构

Fujimoto Pharmaceutical Corp.

在研机构

Fujimoto Pharmaceutical Corp.

非在研机构-

最高研发阶段批准上市

首次获批日期

日本 (1970-03-31),

便秘

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

9

项与决明提取物相关的临床试验

NCT04930237

/ WithdrawnN/AIIT

RELISTOR's Effects on Opioid-Induced Constipation in Postoperative 1-2 Level Anterior Lumbar Interbody Fusion Patients: A Case-Control Study

This will be a prospective case-control study of 40 patients undergoing 1-2 level ALIF procedures at Methodist Dallas Medical Center (MDMC). Patient records will be reviewed to identify details including demographics, comorbidities, procedure details, and the primary and secondary outcome metrics.

开始日期2021-07-01

申办/合作机构

Methodist Health System, Inc.

NCT03501498

/ CompletedN/AIIT

The Effect of Intestinal Transit on the Entrohepatic Circulation of Bile Salts, Faecal Microbiome and Production of Volatile Organic Compounds

A study to determine the influence of changing intestinal transit time of the enterohepatic recirculation of bile acids.

开始日期2017-04-10

申办/合作机构

Plymouth Hospitals NHS Trust

NCT02977286

/ Terminated临床4期IIT

Impact of Naloxegol on Prevention of Lower GI Tract Paralysis in Critically Ill Adults Initiated on Scheduled Intravenous Opioid Therapy: A Randomized, Double-Blind, Placebo-Controlled, Phase II, Single-Center, Proof of Concept Study

This study evaluates the addition of naloxegol (Movantik) to a laxative protocol in critically ill adults requiring scheduled opioid (e.g. fentanyl) therapy. Half of the participants will receive naloxegol and a laxative protocol and half the participants will receive a placebo and a laxative protocol.

开始日期2017-01-01

申办/合作机构

Tufts Medical Center, Inc.

100 项与决明提取物相关的临床结果

登录后查看更多信息

100 项与决明提取物相关的转化医学

登录后查看更多信息

100 项与决明提取物相关的专利（医药）

登录后查看更多信息

2

项与决明提取物相关的文献（医药）

1965-01-01·Antimicrobial agents and chemotherapy

New antibiotics produced by Streptomyces caelestis.

Article

作者: Mason, D J ; Meyer, C E

1957-12-14·BMJ

Action of Senna

Article

作者: Goulding, R. ; Douthwaite, A. H.

100 项与决明提取物相关的药物交易

登录后查看更多信息

研发状态

10 条最早获批的记录,

登录

后查看更多信息

适应症	国家/地区	公司	日期
便秘	日本	Fujimoto Pharmaceutical Corp.	1970-03-31

登录后查看更多信息

临床结果

适应症

分期

评价

查看全部结果

研究	分期	人群特征	评价人数	分组	结果	评价	发布日期


NCT02977286 (CTgov)	临床4期	便秘	12	Polyethylene Glycols+Magnesium Citrate Oral Liquid Product+Bisacodyl 10 mg Suppository+Docusate Sodium 100 Mg oral capsule [Colace]+Senna 217 Mg Oral Tablet+Naloxegol Oral Tablet+Methylnaltrexone (Naloxegol Oral Tablet)	顧構鏇醖糧鑰淵範範鹹(蓋廠廠繭積網範網糧製) = 顧醖遞願積襯鬱製醖壓衊獵憲顧製觸壓醖顧鏇 (鬱窪艱製顧衊願艱壓膚, 憲網鏇築膚簾醖憲構膚 ~ 夢築繭積窪廠顧壓願糧) 更多	-	2023-02-16
				Placebo Oral Tablet+Magnesium Citrate Oral Liquid Product+Bisacodyl 10 mg Suppository+Docusate Sodium 100 Mg oral capsule [Colace]+Senna 217 Mg Oral Tablet+Methylnaltrexone (Placebo Oral Tablet)	顧構鏇醖糧鑰淵範範鹹(蓋廠廠繭積網範網糧製) = 鹹範窪鹽範蓋遞憲選範衊獵憲顧製觸壓醖顧鏇 (鬱窪艱製顧衊願艱壓膚, 鹽積壓夢觸獵顧壓願憲 ~ 簾齋膚製鑰構範遞夢築) 更多
NCT02383758 (CTgov)	N/A	自闭症谱系障碍 \| 自闭症 \| 大便弄脏	22	Glycerin Suppository+Bisacodyl suppository+Senna (Treatment Program)	選願壓範築齋餘艱構醖(餘獵夢艱築膚膚餘鹹獵) = 襯廠選製壓鹽窪窪襯遞積膚簾鹽築獵構鏇壓網 (簾鏇憲築積齋遞觸憲鹽, 製構壓鹹窪鹽構製夢鏇 ~ 網鏇製廠顧獵積廠廠襯) 更多	-	2018-01-11
				Glycerin Suppository+Bisacodyl suppository+Senna (Waitlist Control)	選願壓範築齋餘艱構醖(餘獵夢艱築膚膚餘鹹獵) = 鹽淵範夢壓淵鬱夢鬱鏇積膚簾鹽築獵構鏇壓網 (簾鏇憲築積齋遞觸憲鹽, 鏇繭鏇憲淵築夢鬱鏇鹹 ~ 壓齋餘鹹餘鏇觸製鹹鹹) 更多